In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...

Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, ...

Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. Companies specializing in drug ...

Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using ...

Scientists have engineered bacteria to turn plastic waste into paracetamol, offering a sustainable new path for medicine and ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...

Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely ...

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

Royalty Pharma said on Tuesday will pay up to $2 billion to Revolution Medicines to support the companies' plans for global development and commercialization of the experimental cancer drug ...

A San Francisco-based start-up has cleared a key hurdle to earning conditional approval from the FDA for a daily pill that ...